Biomarker | Patients / Models | Samples | Proposed Action in Stroke | Reference |
---|---|---|---|---|
CXCR4 | MCAO Mice | Brain tissue | Angiogenesis via SDF-1/CXCR4 pathway | [177] |
 | MCAO Mice | Brain tissue | Angiogenesis | [179] |
 | stroke patients | Serum | Stroke-induced mesenchymal stem cell migration | [180] |
VEGF | MCAO rats | Brain tissue | Promotion of angiogenesis and neurogenesis | [283] |
 | CD-1 mice | VEGF protein | Promotion of angiogenesis | [284] |
 | MCAO Rats | Brain tissue | Amplification of angiogenesis and vascular stabilization | |
MMP-9 | MCAO Mice | Brain tissue | Promotion of angiogenesis and glial scar degradation | [184] |
PDGF | human umbilical vein endothelial cells / Fertilized chicken embryos | endothelial cells | Augmentation of angiogenesis | [190] |
PDGF-D | MCAO Mice | Brain tissue | Contribution to neovascularization by rescuing pericyte functions | [189] |
PDGF-BB | Stroke Patients | plasma | Plasma biomarker analysis | [191] |
PTX3 | acute cerebral infarction Patients | plasma | Biomarker analysis | [287] |
 | MCAO Mice | Brain tissue | Promotion of angiogenesis and neuronal survival | [187] |
IL-6 | Cerebrovascular injury Model | Brain tissue | Repair of damaged brain vasculature | [194] |
 | MCAO mice | Brain tissue | Angiogenesis and functional recovery | [288] |
IL-8 | MCAO rats | Brain tissue | Increase in VEGF production and angiogenesis | [192] |
TGF-β | MCAO Mice | oxygen − glucose deprivation model | Promotion of angiogenesis and repression of apoptosis | [185] |
caveolin-1 | MCAO Mice | Brain tissue | Neovascularization and astrogliosis | [186] |
 | patients with Moyamoya disease | plasma | Biomarker analysis | [289] |
MiRNA-26a | MCAO Rats | Brain tissue | Promotion of angiogenesis | |
miR‑210 | MCAO Mice | Brain tissue | Promotion of angiogenesis | [202] |
lncRNA HOTAIR | OGD hBMVECs cell/neonatal patients with HIE | Plasma / cell | Promotion of angiogenesis | [203] |